Citius Oncology, Inc. (CTOR)

Profile

Full Name

Citius Oncology, Inc.

Ticker

NASDAQ: CTOR

Exchange

NASDAQ

Sector

Healthcare

Industry

Specialty & Generic Drug Manufacturers

Country

United States

IPO

Indexes

Not included

Website

-

Employees

-

Key Details

Price

$1.86(1.09%)

Market Cap

$145.77M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$0.00(0.00% YoY)

Annual EPS

-$0.31(-74.41% YoY)

PE Ratio

-

Next earnings date

Dec 26, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.86
    CTOR price is $1.86

    30-Day Relative Volume

    1.28
    CTOR 30-day relative volume is 1.28

    Price Performance

    Price 1-Day Change

    +1.09%
    CTOR price is up +1.09% today

    Price YTD Change

    +61.74%
    CTOR price is up +61.74% since January 1st

    Price 1-Year Change

    +96.83%
    CTOR price is up +96.83% year-on-year

    Price 3-Year Change

    -
    CTOR price 3-year change is unknown

    Price Range

    Price All-Time High

    $49.00
    CTOR price is currently -96.20% below its historical high of $49.00

    Price 3-Year Low

    $0.55
    CTOR price is currently +237.57% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $145.77M
    CTOR market cap is $145.77 million

    Market Cap 3-Year Change

    -
    CTOR market cap 3-year change is unknown

    Market Cap All-Time High

    $2.89B
    CTOR market cap is currently -94.95% below its historical high of $2.89 billion

    Market Cap Sector Percentile

    44.48%
    CTOR market cap is higher than 44.48% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +9.53%
    CTOR shares outstanding is up +9.53% year-on-year

    Shares Outstanding 3-Year Change

    +862.78%
    CTOR shares outstanding is up +862.78% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.00
    CTOR beta is 1.00

    200-day SMA

    $1.47
    CTOR price is currently +26.14% above its 200-day simple moving average

    50-day SMA

    $1.88
    CTOR price is currently -0.98% below its 50-day simple moving average

    14-Day RSI

    45.45
    CTOR 14-day relative strength index is 45.45

    Volume

    1.28
    CTOR 30-day relative volume is 1.28

    ATR

    $0.16
    CTOR average true range is $0.16

    10-day Historical Volatility

    61.64%
    CTOR 10-day historical volatility is 61.64%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CTOR annual revenue is $0.00

    Revenue Analysts Estimate

    -
    CTOR annual revenue consensus analysts' forecast is unknown

    Revenue 1-Year Change

    0%
    CTOR annual revenue has remained unchanged year-on-year

    Revenue Sector Percentile

    28.76%
    CTOR annual revenue is higher than 28.76% of companies in Healthcare sector

    EPS

    EPS

    -$0.31
    CTOR annual earnings per share is -$0.31

    EPS Analysts Estimate

    -$0.33
    CTOR annual earnings per share is currently +5.82% higher than the consensus analysts' forecast

    EPS 1-Year Change

    -74.41%
    CTOR annual earnings per share is down -74.41% year-on-year

    EPS Sector Percentile

    72.55%
    CTOR annual earnings per share is higher than 72.55% of companies in Healthcare sector

    Profit

    Gross Profit

    $0.00
    CTOR annual gross profit is $0.00

    Gross Margin

    -
    CTOR annual gross profit margin value is unknown

    Operating Profit

    -$20.57M
    CTOR annual operating income is -$20.57 million

    Operating Margin

    -
    CTOR annual operating profit margin value is unknown

    Net Income

    -$21.15M
    CTOR annual net profit is -$21.15 million

    Net Margin

    -
    CTOR annual net profit margin value is unknown

    Expenses

    Total Expenses

    $21.15M
    CTOR annual total expenses is $21.15 million

    Operating Expenses

    $20.57M
    CTOR annual total operating expenses is $20.57 million

    Cost Of Goods Sold

    $0.00
    CTOR annual cost of goods sold is $0.00

    Selling, General & Administrative Expenses

    $0.00
    CTOR annual SG&A is $0.00

    Depreciation & Amortization

    -
    CTOR annual D&A value is unknown

    Interest Expense

    $0.00
    CTOR annual interest expense is $0.00

    Income Tax

    $576.00K
    CTOR annual income tax is $576.00 thousand

    EBIT & EBITDA

    EBIT

    -$20.57M
    CTOR annual earnings before interest & taxes is -$20.57 million

    EBITDA

    -$20.57M
    CTOR annual EBITDA is -$20.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $84.37M
    CTOR annual total assets is $84.37 million

    Non Current Assets

    $73.40M
    CTOR annual long term assets is $73.40 million

    Current Assets

    $10.97M
    CTOR annual total current assets is $10.97 million

    Cash and Cash Equivalents

    $100.00
    CTOR annual cash & cash equivalents is $100.00

    Accounts Receivable

    -
    CTOR annual accounts receivable value is unknown

    Inventory

    $8.27M
    CTOR annual inventory is $8.27 million

    Liabilities

    Total Liabilities

    $38.23M
    CTOR annual total liabilities is $38.23 million

    Long Term Liabilities

    $1.73M
    CTOR annual total long term liabilities is $1.73 million

    Current Liabilities

    $32.70M
    CTOR annual current liabilities is $32.70 million

    Accounts Payable

    $3.71M
    CTOR annual accounts payable is $3.71 million

    Debt

    Total Debt

    $3.80M
    CTOR annual total debt is $3.80 million

    Total Debt 1-Year Change

    -
    CTOR annual total debt 1-year change is unknown

    Long Term Debt

    $3.80M
    CTOR annual long term debt is $3.80 million

    Short Term Debt

    $0.00
    CTOR annual short term debt is $0.00

    Equity & Capital

    Shareholders Equity

    $46.14M
    CTOR annual stockholders equity is $46.14 million

    Book Value

    $46.14M
    CTOR annual book value is $46.14 million

    Retained Earnings

    -$39.28M
    CTOR annual retained earnings is -$39.28 million

    Working Capital

    -$21.73M
    CTOR annual working capital is -$21.73 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $126.40K
    CTOR annual cash from operations is $126.40 thousand

    Cash From Operations 1-Year Change

    +100%
    CTOR annual cash from operations is up +100% year-on-year

    Cash From Investing

    -$5.00M
    CTOR annual cash from investing is -$5.00 million

    Cash From Investing 1-Year Change

    -100%
    CTOR annual cash from investing is down -100% year-on-year

    Cash From Financing

    $4.87M
    CTOR annual cash from financing is $4.87 million

    Cash From Financing 1-Year Change

    +100%
    CTOR annual cash from financing is up +100% year-on-year

    CAPEX

    CAPEX

    $0.00
    CTOR annual capital expenditures is $0.00

    CAPEX 1-Year Change

    -
    CTOR annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free Cash Flow

    $126.40K
    CTOR annual free cash flow is $126.40 thousand

    Free Cash Flow 1-Year Change

    +100%
    CTOR annual free cash flow is up +100% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -
    CTOR annual gross profit margin value is unknown

    Operating Margin

    -
    CTOR annual operating profit margin value is unknown

    Net Margin

    -
    CTOR annual net profit margin value is unknown

    ROA & ROE

    ROA

    -26.94%
    CTOR annual return on assets is -26.94%

    ROE

    -36.24%
    CTOR annual return on equity is -36.24%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    CTOR price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    CTOR price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    4.50
    CTOR price to book ratio is 4.50

    PB Ratio Sector Percentile

    73.06%
    CTOR price to book ratio is higher than 73.06% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    -
    CTOR price to sales ratio value is unknown

    PS Ratio Sector Percentile

    -
    CTOR price to sales ratio is unknown

    Enterprise value

    Enterprise Value

    $149.57M
    CTOR enterprise value is $149.57 million

    Enterprise Value Sector Percentile

    49.91%
    CTOR enterprise value is higher than 49.91% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -7.95
    CTOR EV/EBITDA is -7.95

    EV/EBITDA Sector Percentile

    18.56%
    CTOR EV/EBITDA is higher than 18.56% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    0.34
    CTOR annual current ratio is 0.34

    Quick Ratio

    0.08
    CTOR annual quick ratio is 0.08

    Leverage

    Debt To Equity

    0.08
    CTOR annual debt to equity ratio is 0.08

    Interest Coverage Ratio

    -
    CTOR annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    CTOR piotroski f-score value is unknown

    Altman Z-Score

    0.52
    CTOR altman z-score is 0.52

    Analyst ratings

    Recent major analysts updates

    Sep 23, 25 Maxim Group
    Buy
    May 23, 25 Maxim Group
    Hold
    Nov 27, 24 Maxim Group
    Buy
    Aug 13, 24 EF Hutton
    Buy

    Institutional Ownership

    Screeners with CTOR included

    Growing Shares Outstanding
    US stocks
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Best performing stocks YTD
    • What is the ticker symbol for Citius Oncology, Inc.?
    • Does Citius Oncology, Inc. pay dividends?
    • What sector is Citius Oncology, Inc. in?
    • What industry is Citius Oncology, Inc. in?
    • What country is Citius Oncology, Inc. based in?
    • Is Citius Oncology, Inc. in the S&P 500?
    • Is Citius Oncology, Inc. in the NASDAQ 100?
    • Is Citius Oncology, Inc. in the Dow Jones?
    • When was Citius Oncology, Inc.'s last earnings report?
    • When does Citius Oncology, Inc. report earnings?

    What is the ticker symbol for Citius Oncology, Inc.?

    The ticker symbol for Citius Oncology, Inc. is NASDAQ:CTOR

    Does Citius Oncology, Inc. pay dividends?

    No, Citius Oncology, Inc. does not pay dividends

    What sector is Citius Oncology, Inc. in?

    Citius Oncology, Inc. is in the Healthcare sector

    What industry is Citius Oncology, Inc. in?

    Citius Oncology, Inc. is in the Specialty & Generic Drug Manufacturers industry

    What country is Citius Oncology, Inc. based in?

    Citius Oncology, Inc. is headquartered in United States

    Is Citius Oncology, Inc. in the S&P 500?

    No, Citius Oncology, Inc. is not included in the S&P 500 index

    Is Citius Oncology, Inc. in the NASDAQ 100?

    No, Citius Oncology, Inc. is not included in the NASDAQ 100 index

    Is Citius Oncology, Inc. in the Dow Jones?

    No, Citius Oncology, Inc. is not included in the Dow Jones index

    When was Citius Oncology, Inc.'s last earnings report?

    Citius Oncology, Inc.'s most recent earnings report was on August 12, 2025

    When does Citius Oncology, Inc. report earnings?

    The next expected earnings date for Citius Oncology, Inc. is December 26, 2025
    On this page